These tumor subtypes can also be identified with sufficient accuracy during routine diagnosis, using a simple panel of immunohistochemical markers, including antibodies tracing estrogen receptors (ER), progesterone receptors (PR), c-erbB-2 oncoprotein overexpression (HER2), and some myoepithelial markers [3, 4]. The gene discussed is PGR; the disease is neoplasm.